We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

House Committee Greenlights Safety Bill

Law360 (June 20, 2007, 12:00 AM EDT) -- The U.S. House of Representatives Energy and Commerce Committee unanimously approved a bill that would renew drug user fees, strengthen drug safety and would not change current law for pediatric market exclusivity—unlike a bill that passed the U.S. Senate.

After the 39-0 vote Thursday night, the drug user fee can now head to the full House, likely next month.

The legislation must be passed this session because the current bill regarding the fees pharmaceutical companies pay to get their drugs reviewed by the U.S. Food and...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.